Policy and Legislation
Last month, the Institute of Medicine published a much-awaited report which recommends that the Centers for Medicare and Medicaid Services should not adjust Medicare payments geographically, but should continue to focus on value-based payment reforms.
Polls show that few people understand health insurance or the Affordable Care Act. That's especially so for those who have the most to gain from Obamacare: people who are uninsured and haven't had health insurance for a while.
About half the births in the United States are paid for by Medicaid -- a figure higher than previous estimates -- and a new study suggests the numbers could increase as the state-federal health insurance program expands under the Affordable Care Act.
CMS is applying a 1.8 percent payment update to IRF PPS rates for FY 2014, derived from a 2.6 percent market basket update that is reduced by a 0.5 percentage point multi-factor productivity adjustment and an additional 0.3 percentage point reduction as required by the ACA.
A 25 percent cut in the Medicare physician payment rate, driven by the "sustainable growth rate" formula, looms Jan. 1 unless Congress takes action to avert. The American Medical Association's president believes a permanent solution is on the horizon.
It's a little sad to come back from a break and see the same game going on with GOP attempts to stop Obamacare, using the threat of a government shutdown to do it.
While ACOs are touted as a way to help fix an inefficient payment system that rewards more, not better, care, some economists warn they could lead to greater consolidation in the healthcare industry. Here are some answers to common questions about them.
Nancy-Ann DeParle may have left the Obama White House last January, but she did not leave healthcare behind. She spoke with HFN about her healthcare investing strategy as well as broader trends in the healthcare industry.
As healthcare costs for employers continue to rise, they are taking steps to control costs and manage risks.
A recent Moody’s Investment Service report says that several recent developments will likely have long-term consequences for the generic drug industry.